Clinical Trials Browser

OTHER × Neurofibromatoses × 1 year × Clear all

NCT06934928 2026-06-04

Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)

Phase NA Suspended

Neurofibromatosis 1, Neurofibromatoses

NCT07102394 2026-05-08

Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

Phase 1 Recruiting

Neurofibroma, Neurofibromatosis 1, Neurofibromatoses

NCT06147414 2026-04-23

DANNIgene

CNSClassical hematologyGenitourinary

Hydrocephalus, X-linked, Neurofibromatosis-Noonan syndrome, Anemia, Sickle Cell, Hemophilia B, Cystic Fibrosis, Fragile X Syndrome, Hemophilia A, Huntington Disease, Myotonic Dystrophy, Polycystic Kidney, Autosomal Recessive, Neurofibromatoses, Muscular Dystrophy, Duchenne

NCT07233408 2026-02-27

Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy

Phase NA Recruiting

Neurofibromatosis 1, Neurofibromatoses

NCT03873610 2025-12-26

Resiliency Training in Adolescents With NF1 and NF2

Phase NA Active not recruiting

Neurofibromatoses

NCT03406208 2025-12-24

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

Phase NA Completed

Schwannomatosis, Behavior, Neurofibromatosis 1, Neurofibromatosis 2, Neurofibromatoses

NCT07237100 2025-11-19

Mirdametinib in Patients With Advanced NF1-mutant Melanoma

Phase 2 Recruiting

CNSDermatologic

Melanoma, Neurofibromatoses

NCT05581511 2025-10-14

cNF Natural Hx

Active not recruiting

Neurofibroma, Neurofibromatosis 1, Neurofibromatoses

NCT06262113 2025-10-03

A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1

Phase NA Recruiting

Neurofibromatosis 1, Neurofibromatoses

NCT05489783 2025-06-29

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

Glioma, Neurofibromatoses